FDA approved drugs with antiviral activity against SARS-CoV-2: From structure-based repurposing to host-specific mechanisms
FDA 批准的具有抗 SARS-CoV-2 病毒活性的药物:从基于结构的重新利用到宿主特异性机制
期刊:Biomedicine & Pharmacotherapy
影响因子:6.9
doi:10.1016/j.biopha.2023.114614
Mahmoud S Ahmed, Ayman B Farag, Ian N Boys, Ping Wang, Ivan Menendez-Montes, Ngoc Uyen Nhi Nguyen, Jennifer L Eitson, Maikke B Ohlson, Wenchun Fan, Matthew B McDougal, Katrina Mar, Suwannee Thet, Francisco Ortiz, Soo Young Kim, Ashley Solmonson, Noelle S Williams, Andrew Lemoff, Ralph J DeBerardinis
代谢
免疫
微生物学
心血管
新冠
IHC
Donkey
IgY